SGA
AVNR

Sector Gamma AS’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Sector Gamma AS’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-229,400
Closed -$2.73M – 35
2014
Q3 		$2.73M Sell
229,400
-440,000
-66% -$3M 0.64% 31
2014
Q2 		$3.77M Buy
+669,400
New +$3.08M 0.89% 27

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sector Gamma AS's AVNR Position: Q4 2014 in Review

Sector Gamma AS sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 229,400 shares — an estimated $2.73M sold.

Sector Gamma AS first reported a position in AVNR in Q2 2014 and held it in 2 quarters. The position peaked at $3.77M in Q2 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Sector Gamma AS reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Sector Gamma AS sold 229,400 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $2.73M.
  • Sector Gamma AS first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 2 quarters.
  • Sector Gamma AS's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.77M in Q2 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Sector Gamma AS's 13F filing for Q4 2014, filed 17 Feb 2015.